Background Background Few studies have
Few studies have examined the relationship between examined the relationship between antidepressant prescription and receipt of antidepressant prescription and receipt of depression-related disability benefits. depression-related disability benefits.
Aims Aims To address two questions: first, is
To address two questions: first, is prescription of antidepressants in prescription of antidepressants in accordance with published clinical guides accordance with published clinical guides associated with better disability outcomes, associated with better disability outcomes, and second, what is the relationship and second, what is the relationship between guideline-concordant between guideline-concordant antidepressant prescription and length of antidepressant prescription and length of disability? disability?
Method Method An observational study was An observational study was conducted using administrative data from conducted using administrative data from three major Canadian financial and three major Canadian financial and insurance sector companies. Short-term insurance sector companies. Short-term disability and prescription drug claims disability and prescription drug claims records for1996^1998 were linked for records for1996^1998 were linked for workers receiving depression-related workers receiving depression-related short-term disability benefits during that short-term disability benefits during that time. time.
Results

Results Recommended first-line
Recommended first-line agents and recommended doses were agents and recommended doses were significantly associated with return to significantly associated with return to work ( work (w w 2 2 ¼6.64, 6.64, P P5 50.036).In addition, 0.036).In addition, among those who returned to work, early among those who returned to work, early intervention was significantly associated intervention was significantly associated with a shortened disability episode with a shortened disability episode ( (b b¼7 724.1; 95% CI 24.1; 95% CI 7 734.4 to 34.4 to 7 713.8). 13.8).
Conclusions
Conclusions Depression-related Depression-related workplace disabilityis a problem for which workplace disabilityis a problem for which there is no simple solution.These results there is no simple solution.These results provide an additional piece to the puzzle of provide an additional piece to the puzzle of helping workers disabled by depression to helping workers disabled by depression to return to work. return to work.
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The World Health Organization (1996) The World Health Organization (1996) projects that, by 2010, depression will projects that, by 2010, depression will become a leading cause of disability worldbecome a leading cause of disability worldwide. The costs to society promise to be wide. The costs to society promise to be staggering. Greenberg staggering. Greenberg et al et al (1993 Greenberg et al et al ( ) estimate (1993 estimate that society annually loses $43 billion that society annually loses $43 billion (1990 US) because of depression. These (1990 US) because of depression. These losses take two major forms: labour market losses take two major forms: labour market losses and the treatment costs related to losses and the treatment costs related to depression. There is the expectation that depression. There is the expectation that these costs are inversely related; unfortuthese costs are inversely related; unfortunately, there is little published research to nately, there is little published research to support this proposition. Few studies have support this proposition. Few studies have focused on the association between antifocused on the association between antidepressant use and depression-related depressant use and depression-related labour market losses (Fairman labour market losses (Fairman et al et al, , 1998) . One of the main reasons for this 1998). One of the main reasons for this gap is the scarcity of accessible databases gap is the scarcity of accessible databases with which to study this relationship with which to study this relationship (Birnbaum (Birnbaum et al et al, 1999) . This study takes , 1999) . This study takes advantage of a unique data-set linking advantage of a unique data-set linking company occupational health records with company occupational health records with short-term disability and drug benefit short-term disability and drug benefit claims. With this data-set, we take a first claims. With this data-set, we take a first step towards describing the relationship step towards describing the relationship between patterns of antidepressant use between patterns of antidepressant use and return to work from disability. Focusand return to work from disability. Focusing on a population of workers receiving ing on a population of workers receiving depression-related short-term disability depression-related short-term disability benefits, we seek to answer two questions. benefits, we seek to answer two questions. First, is use of antidepressants in accorFirst, is use of antidepressants in accordance with published clinical guidelines dance with published clinical guidelines associated with better disability outcomes? associated with better disability outcomes? Second, what is the relationship between Second, what is the relationship between such guideline-concordant antidepressant such guideline-concordant antidepressant use and the length of disability? use and the length of disability?
Much of the literature on labour Much of the literature on labour market disability focuses on the impact of market disability focuses on the impact of workplace factors on productivity, partiworkplace factors on productivity, particularly the relationship between stress and cularly the relationship between stress and job performance (Van der Heck & Plomp, job performance (Van der Heck & Plomp, 1997) and the role of workplace support 1997) and the role of workplace support systems on disability outcomes (Akabas, systems on disability outcomes (Akabas, 1995) . Only a handful of studies have 1995). Only a handful of studies have examined the relationship between antiexamined the relationship between antidepressant use and outcomes in the workdepressant use and outcomes in the workplace. Using data from a clinical trial, place. Using data from a clinical trial, Berndt Berndt et al et al (1998) found evidence of a (1998) found evidence of a positive relationship between workers' positive relationship between workers' self-perceived low productivity and severity self-perceived low productivity and severity of depression. They also observed that the of depression. They also observed that the use of antidepressants (sertraline and use of antidepressants (sertraline and imipramine) had a significant impact on imipramine) had a significant impact on the severity of depression. One might therethe severity of depression. One might therefore conclude that there is an association fore conclude that there is an association between antidepressant treatment and between antidepressant treatment and workplace functioning. However, Berndt workplace functioning. However, Berndt et al et al did not directly test the impact of antidid not directly test the impact of antidepressant treatment on workplace funcdepressant treatment on workplace functioning, stopping short of examining the tioning, stopping short of examining the direct relationship between antidepressant direct relationship between antidepressant use and productivity. use and productivity.
Mintz Mintz et al et al (1992) pooled data from ten (1992) pooled data from ten studies and used the Social Adjustment studies and used the Social Adjustment Scale in an attempt to measure the direct Scale in an attempt to measure the direct impact of treatment on productivity. They impact of treatment on productivity. They found that their productivity measure was found that their productivity measure was positively associated with treatment, and positively associated with treatment, and also identified symptom remission and also identified symptom remission and length of treatment as the most important length of treatment as the most important predictors of work impairment. However, predictors of work impairment. However, their measure for productivity is difficult their measure for productivity is difficult to translate into policy recommendations. to translate into policy recommendations.
Using administrative data to examine Using administrative data to examine the relationship between absenteeism and the relationship between absenteeism and treatment, Claxton treatment, Claxton et al et al (1999 Claxton et al et al ( ) observed (1999 observed differences between various antidepressants differences between various antidepressants in terms of mean lost work days. Comparin terms of mean lost work days. Comparing two types of antidepressants -tricyclic ing two types of antidepressants -tricyclic antidepressants and selective serotonin antidepressants and selective serotonin reuptake inhibitors (SSRIs) -they found a reuptake inhibitors (SSRIs) -they found a lower average number of days absent for lower average number of days absent for the group using SSRIs. These results offer the group using SSRIs. These results offer an important first step towards underan important first step towards understanding the impact of antidepressant standing the impact of antidepressant treatment on absenteeism. However, they treatment on absenteeism. However, they did not look at or control for other factors did not look at or control for other factors that could also be associated with absentthat could also be associated with absenteeism, such as age, gender and pattern of eeism, such as age, gender and pattern of antidepressant use. antidepressant use.
METHOD METHOD
Data source Data source
This study was conducted using adminiThis study was conducted using administrative data from three major Canadian strative data from three major Canadian financial and insurance sector employers. financial and insurance sector employers. At the time of the project these companies At the time of the project these companies had a combined workforce of approxihad a combined workforce of approximately 63 000 employees nationwide, mately 63 000 employees nationwide, representing about 12% of their sector's representing about 12% of their sector's workforce (Statistics Canada, 1996) . All workforce (Statistics Canada, 1996) . All of the sample companies self-funded and of the sample companies self-funded and self-administered their short-term disability self-administered their short-term disability benefits. This arrangement is representative benefits. This arrangement is representative of many medium-sized to large employers. of many medium-sized to large employers. For example, Watson Wyatt (1997) found For example, Watson Wyatt (1997) found 5 0 7 5 0 7
B R I T I S H J O UR N A L O F P SYC HI AT RY B R I T I S H J O UR N A L O F P S YC H I AT RY
Pattern of antidepressant use and duration Pattern of antidepressant use and duration of depression-related absence from work of depression-related absence from work that 53% of the Canadian firms they that 53% of the Canadian firms they surveyed self-administered their short-term surveyed self-administered their short-term disability benefits, 45% depended on disability benefits, 45% depended on third-party administration (e.g. insurance third-party administration (e.g. insurance carriers) and the remainder were covered carriers) and the remainder were covered by government programmes. by government programmes. Claims were managed by company Claims were managed by company occupational health departments. Thus, occupational health departments. Thus, disability outcomes were identified using disability outcomes were identified using occupational health records. The primary occupational health records. The primary information sources were company shortinformation sources were company shortterm disability claims, prescription drug term disability claims, prescription drug claims and occupational health department claims and occupational health department records. Because of its smaller size, claims records. Because of its smaller size, claims from one company were taken for shortfrom one company were taken for shortterm disability episodes beginning between term disability episodes beginning between January 1996 and December 1998. For January 1996 and December 1998. For the remaining two, data were abstracted the remaining two, data were abstracted for claims beginning in 1997 or 1998. for claims beginning in 1997 or 1998.
Study population Study population
Cases included in our analysis met three Cases included in our analysis met three criteria. First, based on company criteria criteria. First, based on company criteria for short-term disability benefits, claimants for short-term disability benefits, claimants had depression-related absences from work had depression-related absences from work for at least 10 consecutive work days prior for at least 10 consecutive work days prior to their disability leave (starting sample to their disability leave (starting sample n n¼1521). The second criterion required 1521). The second criterion required claimants to have used their prescription claimants to have used their prescription drug benefits at least once during the study drug benefits at least once during the study period for any type of prescription. Sixty period for any type of prescription. Sixty cases were excluded because we could not cases were excluded because we could not ascertain whether the absence of antiascertain whether the absence of antidepressant claims was due to the individual depressant claims was due to the individual not filing a prescription for an antidepresnot filing a prescription for an antidepressant, not receiving a prescription for an sant, not receiving a prescription for an antidepressant, or not using the company's antidepressant, or not using the company's drug benefit plan. The third prerequisite drug benefit plan. The third prerequisite was that the claimant had no more than was that the claimant had no more than one short-term disability episode within one short-term disability episode within the previous 12 months (final sample the previous 12 months (final sample n n¼1281). This criterion helped to ensure 1281). This criterion helped to ensure that the episode included in the data-set that the episode included in the data-set was a distinct episode rather than a conwas a distinct episode rather than a continuation of an earlier one. About 12% of tinuation of an earlier one. About 12% of the claimants had had more than one the claimants had had more than one short-term disability episode in the prior short-term disability episode in the prior 12 months. 12 months.
Short-term disability outcomes Short-term disability outcomes
Three major categories of disability outThree major categories of disability outcomes were observed: comes were observed:
(a) (a) return to work part-time or full-time;
return to work part-time or full-time;
(b) (b) quit, retired or employment terminated; quit, retired or employment terminated;
(c) (c) transition to long-term disability benefits. transition to long-term disability benefits.
Employees in all three participating compaEmployees in all three participating companies were eligible for long-term disability nies were eligible for long-term disability benefits after a total of 6 months on benefits after a total of 6 months on short-term disability. short-term disability.
Length of short-term disability Length of short-term disability (a) (a) 'Use of recommended first-line anti-'Use of recommended first-line antidepressant' indicates whether one of depressant' indicates whether one of the CANMAT first-choice antidepresthe CANMAT first-choice antidepressants was the first drug used during sants was the first drug used during the short-term disability episode. the short-term disability episode. These include the antidepressants These include the antidepressants fluoxetine, fluvoxamine, paroxetine, fluoxetine, fluvoxamine, paroxetine, sertraline, bupropion, moclobemide, sertraline, bupropion, moclobemide, nefazodone and venlafaxine. nefazodone and venlafaxine.
(b) (b) 'Use of recommended antidepressant 'Use of recommended antidepressant dosage' indicates whether the dosage dosage' indicates whether the dosage for the second to last antidepressant for the second to last antidepressant claim fell within the recommended claim fell within the recommended range. range.
(c) (c) 'Antidepressant was received within 30 'Antidepressant was received within 30 days of the initiation of short-term days of the initiation of short-term disability benefits'; this indicator varidisability benefits'; this indicator variable captures whether the antidepresable captures whether the antidepressant prescription was filled either sant prescription was filled either within the 30-day period prior to or within the 30-day period prior to or following the start of the short-term following the start of the short-term disability episode. disability episode.
Complexity of depression Complexity of depression indicators indicators
To reflect the number of symptoms reTo reflect the number of symptoms reported by the claimants, we created a count ported by the claimants, we created a count of the number of depression-related sympof the number of depression-related symptoms recorded on the short-term disability toms recorded on the short-term disability application form. Information was abapplication form. Information was abstracted from occupational health records stracted from occupational health records using a checklist covering the major using a checklist covering the major DSM-IV depressive symptom categories DSM-IV depressive symptom categories (American Psychiatric Association, 1994) . (American Psychiatric Association, 1994) . In previous work we had observed that In previous work we had observed that despite concordance with guidelinedespite concordance with guidelinerecommended first-line agents and use recommended first-line agents and use within recommended time frames, there is within recommended time frames, there is a group of users who experience a complex a group of users who experience a complex course of antidepressant use. These course of antidepressant use. These complex patterns have been reported by complex patterns have been reported by Claxton Claxton et al et al (1999) and Thompson (1999) and Thompson et al et al (1996) . There is evidence that this complex- (1996) . There is evidence that this complexity is associated with a greater need for ity is associated with a greater need for high-intensity health services. This, in turn, high-intensity health services. This, in turn, may be linked to the severity of the episode. may be linked to the severity of the episode. For example, Thompson For example, Thompson et al et al (1996) (1996) observed that those who switched or augobserved that those who switched or augmented their antidepressant use had more mented their antidepressant use had more in-patient hospital use. These findings were in-patient hospital use. These findings were corroborated by Dobrez corroborated by Dobrez et al et al (2000) , who (2000), who reported that these groups of patients use reported that these groups of patients use more health care services overall. Dewa more health care services overall. Dewa et et al al (2003) observed patterns suggesting a (2003) observed patterns suggesting a greater severity of illness and its resistance greater severity of illness and its resistance to treatment: for example, those who to treatment: for example, those who switched and those who had augmented switched and those who had augmented use on average reported a greater number use on average reported a greater number of symptoms than those who either had of symptoms than those who either had one antidepressant fill or used one antione antidepressant fill or used one antidepressant exclusively. This suggests that depressant exclusively. This suggests that the former two groups might have had the former two groups might have had more severe depression, leading to more more severe depression, leading to more problems with treatment. On the basis of problems with treatment. On the basis of previous research (Dewa previous research (Dewa et al et al, 2003) , we , 2003), we created four pattern variables to capture created four pattern variables to capture the complexity of antidepressant use. the complexity of antidepressant use.
(a) (a) 'One fill only' indicates that the clai-'One fill only' indicates that the claimant had only one prescription fill for mant had only one prescription fill for antidepressants during the short-term antidepressants during the short-term disability episode. disability episode.
(b) (b) 'One exclusively' indicates that the 'One exclusively' indicates that the claimant filled more than one prescripclaimant filled more than one prescription for an antidepressant and did not tion for an antidepressant and did not change antidepressants during the change antidepressants during the short-term disability episode. short-term disability episode.
(c) (c) 'Switched' indicates that more than one 'Switched' indicates that more than one prescription was filled and the antiprescription was filled and the antidepressant was changed at least once depressant was changed at least once during the short-term disability during the short-term disability episode. episode.
Augmented' indicates that more than 'Augmented' indicates that more than one prescription was filled and two one prescription was filled and two prescriptions for different antidepresprescriptions for different antidepressants were filled on the same day sants were filled on the same day during the short-term disability during the short-term disability episode. episode.
Analyses Analyses
We began by examining bivariate relationWe began by examining bivariate relationships between variables. Rates of the three ships between variables. Rates of the three disability outcomes were calculated per disability outcomes were calculated per 100 persons. The strength of the asso-100 persons. The strength of the associations between these rates and claimant ciations between these rates and claimant characteristics was tested. The chi-squared characteristics was tested. The chi-squared test was employed to examine the strength test was employed to examine the strength of the association between the outcomes of the association between the outcomes and dichotomous variables. Two-sided and dichotomous variables. Two-sided t t--tests were used to test the associations tests were used to test the associations between continuous variables and antibetween continuous variables and antidepressant use patterns. depressant use patterns.
A two-part multivariable model was A two-part multivariable model was used to examine the effect of guidelineused to examine the effect of guidelinerecommended use of antidepressants on recommended use of antidepressants on return to work. In the first part of the return to work. In the first part of the analysis, we controlled for complexity of analysis, we controlled for complexity of the depression and demographic characthe depression and demographic characteristics using a logistic regression model teristics using a logistic regression model to test whether use of antidepressants to test whether use of antidepressants concordant with recommended use is concordant with recommended use is associated with greater likelihood of associated with greater likelihood of returning to work. In the second part, returning to work. In the second part, we explored the relationship between we explored the relationship between recommended use and days on short-term recommended use and days on short-term disability. For this part of analysis, the disability. For this part of analysis, the study population was subdivided to include study population was subdivided to include only those who returned to work ( only those who returned to work (n n¼997). 997). Using an ordinary least squares regression Using an ordinary least squares regression model, we estimated the association of model, we estimated the association of guideline-recommended use on length of guideline-recommended use on length of short-term disability. short-term disability.
Because there may exist non-random Because there may exist non-random company-specific factors associated with company-specific factors associated with either return to work or length of disability, either return to work or length of disability, company-specific fixed effects were company-specific fixed effects were included in both the first and second part included in both the first and second part of the model. Under ideal conditions, we of the model. Under ideal conditions, we would control for these non-random would control for these non-random factors by including variables that are factors by including variables that are correlated with disability outcomes and correlated with disability outcomes and vary between companies. However, given vary between companies. However, given the limitations inherent in the data, we the limitations inherent in the data, we were unable to adjust explicitly for all were unable to adjust explicitly for all company factors and their contribution to company factors and their contribution to the disability outcomes. Instead, companythe disability outcomes. Instead, companyspecific fixed effects were used to account specific fixed effects were used to account for workplace characteristics without for workplace characteristics without actually measuring them. The company actually measuring them. The company fixed effects allowed us to adjust our fixed effects allowed us to adjust our estimates for unobserved company-related estimates for unobserved company-related heterogeneity. heterogeneity.
RESULTS RESULTS
Demographic characteristics, depression Demographic characteristics, depression severity and antidepressant use patterns severity and antidepressant use patterns for the disability outcomes are shown in for the disability outcomes are shown in Table 1 . A more detailed analysis of the Table 1 . A more detailed analysis of the demographic characteristics of this popudemographic characteristics of this population is given by Dewa lation is given by Dewa et al et al (2002) . (2002). Overall, more than three-quarters of Overall, more than three-quarters of claimants had returned to work by the claimants had returned to work by the end of their short-term disability episode. end of their short-term disability episode. However, there was a difference between However, there was a difference between the disability outcomes of men and the disability outcomes of men and women: significantly more women than women: significantly more women than men returned to work rather than leaving men returned to work rather than leaving employment (difference 10.2%, 95% CI employment (difference 10.2%, 95% CI 2.5-17.9; 2.5-17.9; w w 2 2 ¼8.21, d.f. 8.21, d.f.¼1, 1, P P5 50.004). 0.004). Our severity indicators also suggested Our severity indicators also suggested that there were differences in the severity that there were differences in the severity of symptoms experienced by claimants of symptoms experienced by claimants who did and did not return to work. Those who did and did not return to work. Those who returned to work reported signiwho returned to work reported significantly fewer symptoms than those ficantly fewer symptoms than those who either went on to long-term disability who either went on to long-term disability benefit (mean difference 2.04, 95% benefit (mean difference 2.04, 95% CI 1.6-2.5; CI 1.6-2.5; t t¼1183, 1183, P P5 50.0001) or left 0.0001) or left their employment (mean difference 1.2, their employment (mean difference 1.2, 5 0 9 5 0 9 14.4 14.4 6.3 6.3
1. Statistically significant difference between claimants who returned to work and those who did not return and did not go on to long-term disability benefits ( 1. Statistically significant difference between claimants who returned to work and those who did not return and did not go on to long-term disability benefits (P P5 50.007). 0.007).
2. Statistically significant differences between claimants who returned to work, those who went on to long-term disability ( 2. Statistically significant differences between claimants who returned to work, those who went on to long-term disability (P P5 50.0001) and those who did not return and did not go on 0.0001) and those who did not return and did not go on to long-term disability benefits ( to long-term disability benefits (P P5 50.0001). 0.0001). 3. Statistically significant difference between claimants who went on to long-term disability benefits and those who did not return and did not go on to long-term disability benefits 3. Statistically significant difference between claimants who went on to long-term disability benefits and those who did not return and did not go on to long-term disability benefits ( (P P5 50.02). 0.02). 4. Statistically significant difference between claimants who went on to long-term disability benefits, those who returned to work ( 4. Statistically significant difference between claimants who went on to long-term disability benefits, those who returned to work (P P5 50.0001) and those who did not return and did 0.0001) and those who did not return and did not go on to long-term disability benefits ( not go on to long-term disability benefits (P P5 50.01). 0.01). 5. Statistically significant difference between claimants who returned to work and those who went on to long-term disability benefits ( 5. Statistically significant difference between claimants who returned to work and those who went on to long-term disability benefits (P P5 50.0001). 0.0001).
95% CI 0.7-1.8; 95% CI 0.7-1.8; t t¼4.27, d.f. 4.27, d.f.¼1091, 1091, P P5 50.0001). 0.0001).
More than half of the claimants studied More than half of the claimants studied (56%, 95% CI 53.2-58.6) used anti-(56%, 95% CI 53.2-58.6) used antidepressants. However, antidepressant use depressants. However, antidepressant use differed between the groups who did and differed between the groups who did and did not return to work (Table 2 ). There did not return to work (Table 2 ). There was a higher proportion of antidepressant was a higher proportion of antidepressant use among those who went on to long-term use among those who went on to long-term disability benefits as opposed to those who disability benefits as opposed to those who returned to work ( Among antidepressant users, a majorAmong antidepressant users, a majority were concordant with guideline ity were concordant with guideline recommendations in terms of type of recommendations in terms of type of antidepressant, dose and timing. However, antidepressant, dose and timing. However, there were differences between outcome there were differences between outcome groups. Compared with the two groups groups. Compared with the two groups who did not return to work, a significantly who did not return to work, a significantly larger proportion of the group who larger proportion of the group who returned to work used first-line antireturned to work used first-line antidepressants (difference 5.6%, 95% CI depressants (difference 5.6%, 95% CI 0.2-11.0; 0.2-11.0; w w 2 2 ¼5.13, d.f. 5.13, d.f.¼1, 1, P P5 50.023) and 0.023) and guideline-recommended dosages (differguideline-recommended dosages (difference 10.9%, 95% CI 2.8-18.9; ence 10.9%, 95% CI 2.8-18.9; w w 2 2 ¼7.93, 7.93, d.f. d.f.¼1, 1, P P5 50.005). 0.005). In the first regression model, we In the first regression model, we examined the extent to which return to examined the extent to which return to work is associated with worker characteriswork is associated with worker characteristics, depression complexity or antideprestics, depression complexity or antidepressant use (Table 3) , using a logistic sant use (Table 3) , using a logistic regression. The model's goodness of fit regression. The model's goodness of fit was tested using the Hosmer-Lemeshow was tested using the Hosmer-Lemeshow test. We could not reject the null hypothesis test. We could not reject the null hypothesis that there was an adequate fit with the that there was an adequate fit with the model ( model (w w 2 2 ¼3.74, 3.74, P P5 50.88). The results of 0.88). The results of the first part of the model are reflective of the first part of the model are reflective of those found in the bivariate analyses. The those found in the bivariate analyses. The number of symptoms reported was a signifnumber of symptoms reported was a significant factor associated with return to work. icant factor associated with return to work. The larger the number of symptoms, the The larger the number of symptoms, the smaller the odds ratio (OR smaller the odds ratio (OR¼0.83, 95% CI 0.83, 95% CI 0.78-0.89, 0.78-0.89, P P5 50.0001). In addition, the 0.0001). In addition, the complexity of use indicator variables sugcomplexity of use indicator variables suggested that as antidepressant use became gested that as antidepressant use became more complex, the odds of returning to more complex, the odds of returning to work became lower (e.g. for augmented work became lower (e.g. for augmented use, OR use, OR¼0.16, 95% CI 0.069-0.39, 0.16, 95% CI 0.069-0.39, P P5 50.0001). Age also had a significantly 0.0001). Age also had a significantly negative impact on return to work negative impact on return to work (OR (OR¼0.98, 95% CI 0.97-0.9998, 0.98, 95% CI 0.97-0.9998, P P5 50.047). Finally, although the guideline 0.047). Finally, although the guideline recommendation indicators suggested that recommendation indicators suggested that each had a positive impact on return to each had a positive impact on return to work, individually none was statistically work, individually none was statistically significant. However, this may be due to significant. However, this may be due to the fact that they are highly related to one the fact that they are highly related to one another (i.e. there is multicollinearity another (i.e. there is multicollinearity among the variables), making it difficult among the variables), making it difficult to isolate the impacts of the variables to isolate the impacts of the variables (Gujarati, 1995) . Indeed, the likelihood (Gujarati, 1995) . Indeed, the likelihood ratio test of the joint significance of firstratio test of the joint significance of firstline agent use and recommended dose line agent use and recommended dose showed evidence that together they are showed evidence that together they are associated with return to work ( associated with return to work (w w 2 2 ¼6.64, 6.64, d.f. d.f.¼2, 2, P P5 50.036). 0.036). In the second part of the model, we In the second part of the model, we used an ordinary least squares regression used an ordinary least squares regression model to examine the factors associated model to examine the factors associated with the length of the short-term disability with the length of the short-term disability among those who returned to work. To test among those who returned to work. To test the robustness of our results, we transthe robustness of our results, we transformed the values for days on short-term formed the values for days on short-term disability benefit using both log and square disability benefit using both log and square root transformations and compared these root transformations and compared these results with those using the untransformed results with those using the untransformed values. We found similar results for all values. We found similar results for all three models. For ease of interpretation, three models. For ease of interpretation, we have presented the results using the we have presented the results using the untransformed values for numbers of untransformed values for numbers of short-term disability days. short-term disability days.
Overall, we observed that the mean Overall, we observed that the mean short-term disability episode was 74.2 days short-term disability episode was 74.2 days (95% CI 71.0-77.4). After controlling (95% CI 71.0-77.4). After controlling for demographic characteristics, severity, for demographic characteristics, severity, complexity and company effects, we found complexity and company effects, we found that the use of antidepressants within that the use of antidepressants within 30 days of the start of the disability episode 30 days of the start of the disability episode was significantly associated with the length was significantly associated with the length of episode ( of episode (b b¼7 724.1; 95% CI 24.1; 95% CI 7 734.4 to 34.4 to 7 713.8). On average, compared with those 13.8). On average, compared with those who either delayed use or did not use antiwho either delayed use or did not use antidepressants, there was a 24 day decrease in depressants, there was a 24 day decrease in the length of the short-term disability the length of the short-term disability episode. As in the first part of the model, episode. As in the first part of the model, the results suggested that the number of the results suggested that the number of reported symptoms ( reported symptoms (b b¼7.7, 95% CI 6.3-7.7, 95% CI 6.3-9.0) and complexity of use (e.g. for aug-9.0) and complexity of use (e.g. for augmented use mented use b b¼61.6, 95% CI 37.2-85.9) 61.6, 95% CI 37.2-85.9) were associated with increased length of were associated with increased length of 51 0 51 0 1. Statistically significant difference between claimants who went on to long-term disability benefits, those who returned to work ( 1. Statistically significant difference between claimants who went on to long-term disability benefits, those who returned to work (P P5 50.0001) and those who did not return and did 0.0001) and those who did not return and did not go on to long-term disability benefits ( not go on to long-term disability benefits (P P5 50.01). 0.01). 2. Statistically significant difference between claimants who returned to work and those who did not return and did not go on to long-term disability benefits ( 2. Statistically significant difference between claimants who returned to work and those who did not return and did not go on to long-term disability benefits (P P5 50.003). 0.003). 3. Statistically significant difference between claimants who returned to work and those who went on to long-term disability benefits ( 3. Statistically significant difference between claimants who returned to work and those who went on to long-term disability benefits (P P5 50.009). 0.009).
disability. In addition, the company fixed disability. In addition, the company fixed effects indicated that there was a effects indicated that there was a significant difference in length of disability significant difference in length of disability episode among the participating companies episode among the participating companies (company 1, (company 1, b b¼7 739.7, 95% CI 39.7, 95% CI 7 755.7 to 55.7 to 23.6; company 2, 23.6; company 2, b b¼7 720.6, 95% CI 20.6, 95% CI 7 727.7 to 27.7 to 7 713.6). Finally, the guideline 13.6). Finally, the guideline recommendation indicators for first-line recommendation indicators for first-line agent use and dose in combination were agent use and dose in combination were positively associated with return to work; positively associated with return to work; however, once again, individually neither however, once again, individually neither was statistically significant. was statistically significant.
DISCUSSION DISCUSSION
Our results contribute to the understanding Our results contribute to the understanding of the potential relationship between antiof the potential relationship between antidepressant use and short-term disability depressant use and short-term disability outcomes. These results suggest that antioutcomes. These results suggest that antidepressant use might be a factor in the depressant use might be a factor in the ability of employees to resume their posiability of employees to resume their position in a company. They also begin to tion in a company. They also begin to characterise the role of antidepressants in characterise the role of antidepressants in the management of disability. We observed the management of disability. We observed that about 60% of people claiming that about 60% of people claiming depression-related short-term disability depression-related short-term disability benefits used antidepressant drugs. This benefits used antidepressant drugs. This finding indicates that antidepressant finding indicates that antidepressant pharmacotherapy is a part of the treatment pharmacotherapy is a part of the treatment plan for a large percentage of individuals. It plan for a large percentage of individuals. It reflects findings reported by Olfson reflects findings reported by Olfson et al et al (2002) , who also observed that a large (2002), who also observed that a large proportion of individuals treated for proportion of individuals treated for depression received antidepressants. depression received antidepressants.
First-line agents and return to work First-line agents and return to work
Workers using recommended first-line Workers using recommended first-line agents and recommended doses were signifagents and recommended doses were significantly more likely to return to work rather icantly more likely to return to work rather than to claim long-term disability benefits than to claim long-term disability benefits or leave their employment. These results or leave their employment. These results are congruent with the hypothesis that antiare congruent with the hypothesis that antidepressants can play an important part in depressants can play an important part in the ability of employees to resume work. the ability of employees to resume work.
Early intervention Early intervention
Early intervention and return to work Early intervention and return to work Early intervention was significantly assoEarly intervention was significantly associated with a shortened disability episode ciated with a shortened disability episode among employees on depression-related among employees on depression-related disability benefits who had at least one disability benefits who had at least one antidepressant prescription claim and antidepressant prescription claim and eventually returned to work. Our estimates eventually returned to work. Our estimates indicate that early intervention is associated indicate that early intervention is associated with a reduction in disability episode of with a reduction in disability episode of about 3 weeks. about 3 weeks.
Preliminary estimates of savings associated Preliminary estimates of savings associated with early intervention with early intervention
Given the average weekly wage for this Given the average weekly wage for this sector is about $1011, including 30% for sector is about $1011, including 30% for benefits (Statistics Canada, 2002) , early benefits (Statistics Canada, 2002) , early intervention represents a potential average intervention represents a potential average saving of approximately $3500 (based on saving of approximately $3500 (based on b b¼7 724.1, 95% CI 24.1, 95% CI 7 734.4 to 34.4 to 7 713.8, the 13.8, the range of savings would be $2000-5000) range of savings would be $2000-5000) in terms of reduction in lost productivity in terms of reduction in lost productivity per employee claiming depression-related per employee claiming depression-related short-term disability benefits (all values short-term disability benefits (all values quoted in Canadian dollars). For employees quoted in Canadian dollars). For employees in our study who began using antidepresin our study who began using antidepressants more than 30 days after the start of sants more than 30 days after the start of their episode and returned to work, total their episode and returned to work, total savings could have translated into nearly savings could have translated into nearly $539 000 (range $268 000-875 000). It $539 000 (range $268 000-875 000). It should be noted, however, that this is an should be noted, however, that this is an estimate based on this sample and does estimate based on this sample and does not include the expense of treatment and not include the expense of treatment and other societal costs. Additional research is other societal costs. Additional research is needed to corroborate these findings and needed to corroborate these findings and give a more comprehensive estimate of give a more comprehensive estimate of potential societal benefits. potential societal benefits. 511 511 Potential role of complexity and severity Potential role of complexity and severity of depression of depression
The apparent absence of antidepressant use The apparent absence of antidepressant use might be indicative of a difference in the might be indicative of a difference in the complexity of depression experienced. For complexity of depression experienced. For example, from past analyses we found that example, from past analyses we found that about three-quarters of those who did not about three-quarters of those who did not use antidepressants did not have them use antidepressants did not have them included as part of the short-term disability included as part of the short-term disability care plan reported by their physician. In care plan reported by their physician. In addition, on average, they also reported addition, on average, they also reported lower numbers of symptoms than those lower numbers of symptoms than those who used antidepressants (Dewa who used antidepressants (Dewa et al et al, , 2003) . Finally, those who did not use anti-2003). Finally, those who did not use antidepressants returned to work sooner than depressants returned to work sooner than those who did. Do the absence of antithose who did. Do the absence of antidepressants in the initial treatment plan, depressants in the initial treatment plan, the fewer number of symptoms and the the fewer number of symptoms and the faster return to work suggest that those faster return to work suggest that those who do not use antidepressants have a less who do not use antidepressants have a less complex illness course? Or could these complex illness course? Or could these factors be indicative of lesser severity of factors be indicative of lesser severity of depression than in their counterparts who depression than in their counterparts who used antidepressants? Perhaps these used antidepressants? Perhaps these individuals are relying on other types of individuals are relying on other types of intervention, such as counselling? Does intervention, such as counselling? Does the lack of antidepressant use reflect a the lack of antidepressant use reflect a resistance to adopting a sick role and resistance to adopting a sick role and consequently a more rapid return to work? consequently a more rapid return to work? These questions will be important to These questions will be important to address in future follow-up studies. address in future follow-up studies.
Limitations Limitations
As with most administrative database As with most administrative database studies, our results are limited by the accustudies, our results are limited by the accuracy of the diagnosis on the claim forms racy of the diagnosis on the claim forms (Browne (Browne et al et al, 1998) . In an ideal world , 1998). In an ideal world we would have conducted a clinical assesswe would have conducted a clinical assessment of all individuals in the study to verify ment of all individuals in the study to verify whether they were suffering from a diswhether they were suffering from a disabling episode of depression. However, in abling episode of depression. However, in the interests of feasibility and maintaining the interests of feasibility and maintaining worker anonymity, we chose to study the worker anonymity, we chose to study the population identified as having depression population identified as having depression rather than those confirmed with depresrather than those confirmed with depression. In addition, we focused on only one sion. In addition, we focused on only one aspect of treatment for depression. In future aspect of treatment for depression. In future studies it will be helpful to understand the studies it will be helpful to understand the roles of other treatments such as psychoroles of other treatments such as psychotherapy. Disability management practices therapy. Disability management practices and preventive interventions are other areas and preventive interventions are other areas worth exploring. Furthermore, our reliance worth exploring. Furthermore, our reliance on administrative data constrains our abilon administrative data constrains our ability to comment on compliance (Edgell ity to comment on compliance (Edgell et et al al, 1999) . It is assumed that workers who , 1999). It is assumed that workers who filled prescriptions also took their medicafilled prescriptions also took their medications. To the extent that this is valid, our tions. To the extent that this is valid, our measures of use reflect a combination of measures of use reflect a combination of partial compliance and physicians' prescribpartial compliance and physicians' prescribing patterns. Finally, our study focused on ing patterns. Finally, our study focused on workers who took depression-related disworkers who took depression-related disability leave. Consequently, although this ability leave. Consequently, although this study represents an important first step in study represents an important first step in exploring the role of antidepressants in exploring the role of antidepressants in influencing depression-related short-term influencing depression-related short-term disability, the limitations associated with disability, the limitations associated with an observational study design make our an observational study design make our results more exploratory than definitive. results more exploratory than definitive. We cannot comment on the precise mechanWe cannot comment on the precise mechanism that results in return to work: other ism that results in return to work: other factors, related to receipt of guideline treatfactors, related to receipt of guideline treatments, may affect outcomes. Although we ments, may affect outcomes. Although we have tried to adjust for such confounders have tried to adjust for such confounders by including variables representing socioby including variables representing sociodemographic demographic characteristics, guidelinecharacteristics, guidelinerecommended use, recommended use, type of company and type of company and degree of complexity, the administrative degree of complexity, the administrative data limit the extent to which this could data limit the extent to which this could be done. Use of a randomised controlled be done. Use of a randomised controlled trial design would decrease the opportunity trial design would decrease the opportunity for such a sample selection bias. for such a sample selection bias.
Future research Future research
Our findings point to a number of avenues Our findings point to a number of avenues for future research. Among those who are prescribed antidepressants, one in five seem to require complex care (i.e. switching or augmentation). complex care (i.e. switching or augmentation).
LIMITATIONS LIMITATIONS
& & Because this is an observational study, we are limited to the extent to which we Because this is an observational study, we are limited to the extent to which we can comment on the precise mechanisms that result in return to work. can comment on the precise mechanisms that result in return to work. This study focuses on only one aspect of treatment for depression; in future studies it would be helpful to understand the roles of other treatments and studies it would be helpful to understand the roles of other treatments and interventions. interventions.
& & Reliance on administrative data constrains our ability to comment on compliance Reliance on administrative data constrains our ability to comment on compliance with treatment; it was assumed that workers who filled prescriptions also took their with treatment; it was assumed that workers who filled prescriptions also took their medications. medications. Depression in the workplace is a Depression in the workplace is a problem for which there is no simple problem for which there is no simple solution. The nature of the disability and solution. The nature of the disability and its treatment are complex. This study takes its treatment are complex. This study takes advantage of a unique link between advantage of a unique link between occupational health records and drug occupational health records and drug benefit claims data to examine one aspect benefit claims data to examine one aspect of treatment. The results do not prove a of treatment. The results do not prove a causal link between recommended treatcausal link between recommended treatment and better disability outcome (i.e ment and better disability outcome (i.e greater likelihood of return to work or greater likelihood of return to work or shorter duration of disability). However, shorter duration of disability). However, they provide additional leads to answering they provide additional leads to answering the important questions of how to help the important questions of how to help people disabled by depression return to people disabled by depression return to work. work. 
